Journal of Cancer Research and Clinical Oncology

, Volume 134, Issue 9, pp 953–960 | Cite as

Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules

  • Stergios A. PolyzosEmail author
  • Marina Κita
  • Zoe Efstathiadou
  • Pavlos Poulakos
  • Aristidis Slavakis
  • Danae Sofianou
  • Nikolaos Flaris
  • Maria Leontsini
  • Anargyros Kourtis
  • Avraam Avramidis
Original Paper



Serum thyrotropin (TSH) is a well-established growth factor for thyroid nodules and suppression of TSH concentrations by administering exogenous thyroxine may interfere with the growth of established nodules as well as the formation of new thyroid nodules. The aim of this study was to investigate whether serum TSH at presentation is a predictor of thyroid malignancy in patients with thyroid nodules.


A total of 565 patients without overt thyroid dysfunction, who presented with palpable thyroid nodule(s) between 1988 and 2004 and underwent at least one fine-needle aspiration biopsy, were retrospectively evaluated.


The final diagnostic outcome was established after surgery (n = 122) or after a minimum of 1-year clinical follow-up period. Higher rates of malignancy were observed in patients with serum TSH in the upper tertile of the normal range (= 0.026). Binary logistic regression analysis revealed significantly increased adjusted odds ratios for the diagnosis of malignancy in patients with serum TSH 1.5–4.0 mIU/l when compared to those with either TSH 0.4–0.8 mIU/l (= 0.005) or TSH 0.9–1.4 mIU/l (= 0.007).


The risk of malignancy in thyroid nodules increases in parallel with TSH concentrations within the normal range. TSH concentration at presentation is an independent predictor of thyroid malignancy.


Thyrotropin (TSH) Fine-needle aspiration biopsy (FNAB) Thyroid nodule Thyroid neoplasms Goiter Thyroid cytology Thyroid histology 


  1. Belfiore A, Giuffrida D, La Rosa GL, Ippolito O, Russo G, Fiumara A, Vigneri R, Filetti S (1989) High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh) 121:197–202Google Scholar
  2. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363–369PubMedCrossRefGoogle Scholar
  3. Block MA, Dailey GE, Robb JA (1983) Thyroid nodules indeterminate by needle biopsy. Am J Surg 146:72–78PubMedCrossRefGoogle Scholar
  4. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295–4301PubMedCrossRefGoogle Scholar
  5. Carayon P, Thomas-Morvan C, Castanas E, Tubiana M (1980) Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. J Clin Endocrinol Metab 51:915–920PubMedGoogle Scholar
  6. Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville A, Carr Z, Chumak V, Davis S, Demidchik Y, Drozdovitch V, Gentner N, Gudzenko N, Hatch M, Ivanov V, Jacob P, Kapitonova E, Kenigsberg Y, Kesminiene A, Kopecky KJ, Kryuchkov V, Loos A, Pinchera A, Reiners C, Repacholi M, Shibata Y, Shore RE, Thomas G, Tirmarche M, Yamashita S, Zvonova I (2006) Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 26:127–140PubMedCrossRefGoogle Scholar
  7. Castro MR, Gharib H (2005) Continuing controversies in the management of thyroid nodules. Ann Intern Med 142:926–931PubMedGoogle Scholar
  8. Chang TC, Kuo SH, Liaw KY, Chang CC, Chen FW (1988) Cell kinetics, DNA content and TSH receptor–adenylate cyclase system in differentiated thyroid cancer. Clin Endocrinol (Oxf) 29:477–484CrossRefGoogle Scholar
  9. Chow LS, Gharib H, Goellner JR, van Heerden JA (2001) Nondiagnostic thyroid fine-needle aspiration cytology: management dilemmas. Thyroid 11:1147–1151PubMedCrossRefGoogle Scholar
  10. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142PubMedGoogle Scholar
  11. Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840PubMedCrossRefGoogle Scholar
  12. Franklyn JA, Daykin J, Young J, Oates GD, Sheppard MC (1993) Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules. BMJ 307:240–240PubMedGoogle Scholar
  13. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK (2006) Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 91:3411–3417PubMedCrossRefGoogle Scholar
  14. Garcia-Mayor RV, Perez Mendez LF, Paramo C, Luna CR, Rego IA, Regal M, Sierra JM, Fluiters E (1997) Fine-needle aspiration biopsy of thyroid nodules: impact on clinical practice. J Endocrinol Invest 20:482–487PubMedGoogle Scholar
  15. Gharib H, Goellner JR (1993) Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282–289PubMedGoogle Scholar
  16. Gharib H, Goellner JR, Zinsmeister AR, Grant CS, Van Heerden JA (1984) Fine-needle aspiration biopsy of the thyroid: the problem of suspicious cytologic findings. Ann Intern Med 101:25–28PubMedGoogle Scholar
  17. Goldberg RC, Lindsay S, Nichols CW, Chaikoff IL (1964) Induction of neoplasms in thyroid glands of rats by subtotal thyroidectomy and by the injection of one microcurie of I-131. Cancer Res 24:35–43PubMedGoogle Scholar
  18. Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12:20–37PubMedCrossRefGoogle Scholar
  19. Hegedus L (2001) Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339–360PubMedCrossRefGoogle Scholar
  20. Hegedus L (2004) Clinical practice: the thyroid nodule. N Engl J Med 351:1764–1771PubMedCrossRefGoogle Scholar
  21. Hegedus L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102–132PubMedCrossRefGoogle Scholar
  22. Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, Lee HK, Hong SJ, Shong YK (2004) Ultrasonographic screening for detection of thyroid cancer in patients with Graves’ disease. Clin Endocrinol (Oxf) 60:719–725CrossRefGoogle Scholar
  23. Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T (2002) Risk factors for goiter and thyroid nodules. Thyroid 12:879–888PubMedCrossRefGoogle Scholar
  24. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48:6–29PubMedCrossRefGoogle Scholar
  25. Mann K (1998) Evaluation of risk in autonomously functioning thyroid nodules. Exp Clin Endocrinol Diabetes 106 Suppl 4:23–26CrossRefGoogle Scholar
  26. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ (2000) Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133:696–700PubMedGoogle Scholar
  27. McCall A, Jarosz H, Lawrence AM, Paloyan E (1986) The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 100:1128–1132PubMedGoogle Scholar
  28. McHenry C, Smith M, Lawrence AM, Jarosz H, Paloyan E (1988) Nodular thyroid disease in children and adolescents: a high incidence of carcinoma. Am Surg 54:444–447PubMedGoogle Scholar
  29. Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R, Maggio M, Valenti G, Ceresini G (2005) Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Invest 28:101–104PubMedGoogle Scholar
  30. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803PubMedCrossRefGoogle Scholar
  31. Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabbrini R, Pacella CM (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780–783PubMedCrossRefGoogle Scholar
  32. Polyzos SA, Kita M, Avramidis A (2007) Thyroid nodules—stepwise diagnosis and management. Hormones (Athens) 6:101–119Google Scholar
  33. Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C (1996) Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 81:4318–4323PubMedCrossRefGoogle Scholar
  34. Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Draeger PM (2004) Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14:926–932PubMedCrossRefGoogle Scholar
  35. Ross DS (2006) Editorial: predicting thyroid malignancy. J Clin Endocrinol Metab 91:4253–4255PubMedCrossRefGoogle Scholar
  36. Schneider AB, Bekerman C, Leland J, Rosengarten J, Hyun H, Collins B, Shore-Freedman E, Gierlowski TC (1997) Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 82:4020–4027PubMedCrossRefGoogle Scholar
  37. Tollin SR, Mery GM, Jelveh N, Fallon EF, Mikhail M, Blumenfeld W, Perlmutter S (2000) The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 10:235–241PubMedGoogle Scholar
  38. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493CrossRefGoogle Scholar
  39. Tuttle RM, Lemar H, Burch HB (1998) Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8:377–383PubMedCrossRefGoogle Scholar
  40. Vander JB, Gaston EA, Dawber TR (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69:537–540PubMedGoogle Scholar
  41. Werk EE, Vernon BM, Gonzalez JJ, Ungaro PC, McCoy RC (1984) Cancer in thyroid nodules. A community hospital survey. Arch Intern Med 144:474–476PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Stergios A. Polyzos
    • 1
    Email author
  • Marina Κita
    • 1
  • Zoe Efstathiadou
    • 1
  • Pavlos Poulakos
    • 1
  • Aristidis Slavakis
    • 2
  • Danae Sofianou
    • 2
  • Nikolaos Flaris
    • 3
  • Maria Leontsini
    • 3
  • Anargyros Kourtis
    • 1
  • Avraam Avramidis
    • 1
  1. 1.Department of EndocrinologyHippokratio General HospitalThessalonikiGreece
  2. 2.Department of MicrobiologyHippokratio General HospitalThessalonikiGreece
  3. 3.Department of PathologyHippokratio General HospitalThessalonikiGreece

Personalised recommendations